HoneyNaps

HoneyNaps Gains CRO Status, Expands AI Sleep Data Services for Pharma

Boston – October 01, 2026 -- HoneyNaps, an AI-based sleep health technology company, has completed registration as a clinical research organization (CRO) with South Korea's National Enterprise for Clinical Trials (KoNECT), broadening its role in pharmaceutical and medical device trials worldwide.

HoneyNaps secures CRO registration with KoNECT, expanding multicenter trial capacity

The company has supported clinical trials involving more than 10,000 participants and can now operate multicenter, multidisciplinary studies under its new CRO status. The registration formalizes HoneyNaps' position as a provider of standardized sleep data analysis for pharmaceutical companies, medical device developers, and research organizations.

HoneyNaps Cuts 24 PSG Wires to Four Wireless Skin Patches

Boston – September 08, 2026 -- HoneyNaps has developed a wireless polysomnography (PSG) system that replaces more than 24 wired sensors with four compact skin patches, combining patch-based sensing with AI-driven sleep analysis.

System consolidates dozens of wired sensors into four wearable patches

Conventional PSG, the standard diagnostic test for sleep disorders such as sleep apnea, typically requires patients to spend a night in a hospital wired to more than 24 sensors placed across the face, chest, abdomen and legs. HoneyNaps' Wireless PSG system instead uses a Head Sensor, Chest Sensor, Body Sensor and Leg Sensor to capture EEG, EOG, ECG, EMG, respiratory airflow, SpO2, body position and physical activity without cables.